Recombinant Human KLK12 Protein，His

KLK12, or Kallikrein-related peptidase 12, is part of the kallikrein-related peptidase family, which comprises serine proteases implicated in various physiological and pathological processes. Research on KLK12 has gained significance due to its potential roles in human health, including its association with cancers, particularly in the context of tumor progression and metastasis. Elevated levels of KLK12 have been observed in certain types of cancer, suggesting its possible utility as a biomarker for diagnosis or prognosis. Additionally, KLK12 is thought to be involved in the modulation of the extracellular matrix, influencing cell migration and invasion, which are critical factors in cancer biology. Furthermore, its involvement in physiological processes such as tissue remodeling and inflammatory responses positions KLK12 as a potential therapeutic target. Current studies aim to elucidate the exact mechanisms by which KLK12 exerts its effects, exploring its interactions with other proteins and its regulation in various cellular contexts. Understanding KLK12's structure-function relationship through recombinant protein studies can provide insights into its biological roles and pave the way for the development of novel diagnostic and therapeutic strategies. The ongoing research focuses on the characterization of KLK12's enzymatic activity, substrate specificity, and the impact of its dysregulation in disease states, highlighting the importance of this protein in both basic and clinical research.